Researchers led by CMTA-STAR Advisory Board member Vincent Timmerman, PhD, at the University of Antwerp are developing human-derived CMT1A organoids using patient-derived stem cells. This research platform aims to improve understanding of disease mechanisms and provide a standardized model for evaluating potential treatments.
Development of a new CMT1A research toolbox: an alternative human stem cell-based strategy
With CMTA support of $98,890, researchers at Hasselt University in Belgium, led by Esther Wolfs,...
